Maik Haentschel (Maik Häntschel)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Idiopathic Pulmonary Fibrosis

Top Venues

Journal of clinical medicine

Thoracic cancer

Chronic respiratory disease

Molecular diagnosis & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jürgen Hetzel, Laetitia A Mauti, Jonas Winkler, Sabine Cardoso Almeida, Philip Jermann, Miklos Pless, Lukas Bubendorf, Peter Karl Bode, Maik Haentschel
Only EBUS-Guided Mediastinal Lymph Node Cryobiopsy Enabled Immunotherapy in a Patient with Non-Small Cell Lung Cancer. Journal of clinical medicine 12 (6) (2023)
Jürgen Hetzel, Laetitia A Mauti, Jonas Winkler, Sabine Cardoso Almeida, Philip Jermann, Miklos Pless, Lukas Bubendorf, Peter Karl Bode, Maik Haentschel
Only EBUS-Guided Mediastinal Lymph Node Cryobiopsy Enabled Immunotherapy in a Patient with Non-Small Cell Lung Cancer. Journal of clinical medicine 12 (6) (2023)
Jürgen Hetzel, Laetitia A Mauti, Jonas Winkler, Sabine Cardoso Almeida, Philip Jermann, Miklos Pless, Lukas Bubendorf, Peter Karl Bode, Maik Haentschel
Only EBUS-Guided Mediastinal Lymph Node Cryobiopsy Enabled Immunotherapy in a Patient with Non-Small Cell Lung Cancer. Journal of clinical medicine 12 (6) (2023)
Juergen Hetzel, Michael Boeckeler, Richard A Lewis, Marius Horger, Maik Haentschel
Use of 3-D navigation to target the site of autologous blood installation for lung volume reduction in bullous emphysema. Chronic respiratory disease 17 (2021)
Barbara L Melosky, Karl-Otto Kambartel, Maik Haentschel, Margherita Bennetts, Dana J Nickens, Julia Brinkmann, Antonin Kayser, Michael Moran, Federico Cappuzzo
Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis. Molecular diagnosis & therapy (2021)
Maik Haentschel, Johannes Niebling, Almut Häring, Max-Felix Häring, Thorben Groß, Marius Horger, Reimer Riessen, Michael Haap, Richard A Lewis, Michael Böckeler, Jürgen Hetzel
Life-threatening pneumonitis after first-line treatment with osimertinib for primary T790M mutated non-small cell lung cancer. Thoracic cancer 11 (7) (2020)